Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Resat Cinar

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
JACC. Cardiovascular Imaging|February 8, 2018
Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational ApproachInes Valenta, Zoltan V Varga, Heather Valentine, et al.
Iscience|August 3, 2023
Cannabinoid receptor type 1 (CB<sub>1</sub>R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3Gergő Szanda, Tony Jourdan, Éva Wisniewski, et al.
Hepatology (Baltimore, Md.)|April 10, 2018
Disruption of Renal Arginine Metabolism Promotes Kidney Injury in Hepatorenal Syndrome in MiceZoltan V Varga, Katalin Erdelyi, Janos Paloczi, et al.
Chemistry & Biology|November 25, 2010
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effectsGrzegorz Godlewski, Shakiru O Alapafuja, Sándor Bátkai, et al.
Respiratory Research|May 5, 2022
Progressive pulmonary fibrosis in a murine model of Hermansky-Pudlak syndromeShachar Abudi-Sinreich, Steven P Bodine, Tadafumi Yokoyama, et al.
ACS Pharmacology & Translational Science|June 21, 2021
Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB<sub>1</sub>R) AntagonistZiyi Liu, Malliga R Iyer, Grzegorz Godlewski, et al.
Cell Metabolism|July 31, 2012
Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistanceJoseph Tam, Resat Cinar, Jie Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary FibrosisResat Cinar, Abhishek Basu, Muhammad Arif, et al.
American Journal of Respiratory and Critical Care Medicine|January 22, 2025
Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary FibrosisResat Cinar, Abhishek Basu, Muhammad Arif, et al.
British Journal of Pharmacology|September 24, 2015
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicityPartha Mukhopadhyay, Marc Baggelaar, Katalin Erdelyi, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
JACC. Cardiovascular Imaging|February 8, 2018
Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational ApproachInes Valenta, Zoltan V Varga, Heather Valentine, et al.
Iscience|August 3, 2023
Cannabinoid receptor type 1 (CB<sub>1</sub>R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3Gergő Szanda, Tony Jourdan, Éva Wisniewski, et al.
Hepatology (Baltimore, Md.)|April 10, 2018
Disruption of Renal Arginine Metabolism Promotes Kidney Injury in Hepatorenal Syndrome in MiceZoltan V Varga, Katalin Erdelyi, Janos Paloczi, et al.
Chemistry & Biology|November 25, 2010
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effectsGrzegorz Godlewski, Shakiru O Alapafuja, Sándor Bátkai, et al.
Respiratory Research|May 5, 2022
Progressive pulmonary fibrosis in a murine model of Hermansky-Pudlak syndromeShachar Abudi-Sinreich, Steven P Bodine, Tadafumi Yokoyama, et al.
ACS Pharmacology & Translational Science|June 21, 2021
Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB<sub>1</sub>R) AntagonistZiyi Liu, Malliga R Iyer, Grzegorz Godlewski, et al.
Cell Metabolism|July 31, 2012
Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistanceJoseph Tam, Resat Cinar, Jie Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary FibrosisResat Cinar, Abhishek Basu, Muhammad Arif, et al.
American Journal of Respiratory and Critical Care Medicine|January 22, 2025
Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary FibrosisResat Cinar, Abhishek Basu, Muhammad Arif, et al.
British Journal of Pharmacology|September 24, 2015
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicityPartha Mukhopadhyay, Marc Baggelaar, Katalin Erdelyi, et al.
Pageof 10